Journal of Kidney Cancer and VHL

Kidney Cancer And VHL
publishes research & review articles related to kidney cancer and VHL

[Journal of Kidney Cancer and VHL @Jokcov]

A randomized study compared pre-op embolization vs “on-clamp” laparoscopic partial nephrectomy for T1 RCC, focusing on bleeding control, recovery, and kidney preservation.
Read more: https://t.co/wzi0IQWY1j
#RCC #KidneyCancer #CancerResearch

[Journal of Kidney Cancer and VHL @Jokcov]

Percutaneous cryoablation is effective for RCC but may carry risks like portal venous thrombosis. Follow-up is key.

Read more: https://t.co/SetWEETsT2

#RCC #KidneyCancer #Oncology #CancerResearch

[Journal of Kidney Cancer and VHL @Jokcov]

A study from Rasool Akram Hospital (2018–2021) highlights neurological symptoms and imaging findings in VHL patients, improving understanding of nervous system involvement.
Read more: https://t.co/WnJDLQmlx5
#VHL #KidneyCancer #RCC #CancerResearch

[Journal of Kidney Cancer and VHL @Jokcov]

Visfatin may be linked to renal cell carcinoma progression and could become a future treatment target.
Read more: https://t.co/qTtsEJJKgG

#RCC #KidneyCancer #CancerResearch

[Journal of Kidney Cancer and VHL @Jokcov]

Partial nephrectomy is emerging as an important option for oligometastatic cancer, helping preserve healthy kidney tissue while targeting tumors—offering improved outcomes and quality of life.
Read more: https://t.co/WdiJ8zW1em
#RCC #Oncology #CancerResearch

[Journal of Kidney Cancer and VHL @Jokcov]

VHL syndrome can be linked to complications like diabetes, lung nodules & thyroid nodules. Family history or symptoms? Early screening is key for better outcomes.

Read more: https://t.co/0wHbtyL9Cj

#KidneyCancer #RCC #Oncology #CancerResearch

[Journal of Kidney Cancer and VHL @Jokcov]

Active surveillance for small renal masses is gaining ground—a Danish cohort study highlights better patient selection to avoid unnecessary surgery and improve outcomes.
https://t.co/gzu1e01QxC

#KidneyCancer #OncologyResearch

[Journal of Kidney Cancer and VHL @Jokcov]

Bioinformatics reveals BCL11A, NTN5 & OGN as promising biomarkers for pRCC—offering potential for earlier detection and more personalized treatment strategies.
https://t.co/fXOsM4Fbmj

#KidneyCancer #OncologyResearch

[Journal of Kidney Cancer and VHL @Jokcov]

MTSCC is a rare kidney cancer that can be challenging to diagnose—early detection and timely care are key to better outcomes.
https://t.co/rM0arDtBKF

#KidneyCancer #OncologyResearch

[Journal of Kidney Cancer and VHL @Jokcov]

Real-world data from TriNetX is enhancing our understanding of VHL disease—revealing treatment patterns and outcomes to improve patient care strategies.
https://t.co/Y9UQtgzDfv

#KidneyCancer #OncologyResearch

[Journal of Kidney Cancer and VHL @Jokcov]

New data highlights avoidable surgeries for benign kidney tumors—emphasizing the importance of careful monitoring and decision-making to improve patient outcomes.
https://t.co/hhYo1c7ouG

#KidneyCancer #OncologyResearch

[Journal of Kidney Cancer and VHL @Jokcov]

IKCS Europe 2026 abstracts spotlight the latest advances in kidney cancer—spanning diagnosis, biomarkers, and emerging therapies shaping future care.
https://t.co/BaFilWgfzZ

#KidneyCancer #OncologyResearch

[Journal of Kidney Cancer and VHL @Jokcov]

Proceedings of IKCS North America 2025 highlight cutting-edge research, emerging therapies, and key insights shaping the future of kidney cancer care.

https://t.co/phSj1q6jyg

#KidneyCancer #OncologyResearch

[Journal of Kidney Cancer and VHL @Jokcov]

Tumor margin matters after partial nephrectomy—but new research suggests margin length may be just as crucial in predicting kidney cancer recurrence. Smarter surgical decisions could improve long-term outcomes.

https://t.co/x2RwZpiQyR

#KidneyCancer #OncologyResearch

[Journal of Kidney Cancer and VHL @Jokcov]

T1 renal tumours can be managed with strategies like preoperative super-selective embolization or on-clamp laparoscopic partial nephrectomy—comparing outcomes, blood loss, and recovery helps optimize patient care.

Read more: https://t.co/wzi0IQWqbL

#KidneyCancer #RCC

[Journal of Kidney Cancer and VHL @Jokcov]

After percutaneous cryoablation for RCC, vigilant follow-up is crucial. Rare complications like portal venous thrombosis highlight the need for early imaging and clinical monitoring to ensure patient safety.

Read more: https://t.co/SetWEEU0IA

#KidneyCancer #RCC #OncologyCare

[Journal of Kidney Cancer and VHL @Jokcov]

Von Hippel–Lindau (VHL) disease shows distinctive imaging patterns that help detect associated tumours early—enabling timely monitoring and better management of this hereditary condition.
Read more: https://t.co/ewgXFCBsEm

#KidneyCancer #RCC #VHLdisease

[Journal of Kidney Cancer and VHL @Jokcov]

Kidney tumour location affects surgical planning—posterior vs. antero-lateral tumours pose different challenges in retroperitoneal laparoscopic partial nephrectomy, guiding the choice of approach.

Read more: https://t.co/lwSmq1myuA

#KidneyCancer #RCC #UrologicSurgery

[Journal of Kidney Cancer and VHL @Jokcov]

Age alone shouldn’t determine genetic testing for hereditary kidney cancer. Family history, clinical features, and tumor type are also crucial for identifying at-risk individuals.

Read more: https://t.co/ZyCfHdkbIE

#KidneyCancer #RCC #GeneticTesting

[Journal of Kidney Cancer and VHL @Jokcov]

Chromophobe RCC is a rare subtype, but sarcomatoid differentiation can signal a more aggressive course. Recognising these changes is key for prognosis and treatment decisions.

🔗 Read more: https://t.co/ZyCfHdkbIE

#KidneyCancer #RCC #Oncology #CancerResearch #Pathology